[{"Assets_0_Q3_USD":17505000.0,"CommonStockSharesOutstanding_0_Q3_shares":35668685.0,"NetIncomeLoss_3_Q3_USD":-12369000.0,"NetIncomeLoss_1_Q3_USD":-5140000.0,"StockholdersEquity_0_Q3_USD":12510000.0,"Ticker":"EYPT","CIK":"1314102","name":"PSIVIDA CORP.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170508"}]